Rossi Residencial S.A (RSID3) Fair Value & Analysis
Consumer Cyclical · BR · Market cap R$32.0M
Fair value as of: Jul 11, 2026
From 24 valuation models · updated today
Fair value updated Jul 11, 2026 — revised from R$37.86 to R$1.20 (−96.8%) since Jun 24, 2026.
Price vs Fair Value (12 months)
12‑month range R$1.45 – R$2.07 · fair‑value band R$0.4073 – R$1.76 · the R$1.60 price screens above the R$1.20 fair value. As of Jul 11, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Rossi Residencial S.A (RSID3) currently trades at R$1.60, while our model-based Fair Value estimate is R$1.20 — implying the stock looks roughly 25.2% overvalued today. We read business quality at 47/100 (below-average quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, Rossi Residencial S.A generated revenue of R$146M at a net margin of 58.3%. Net debt stands at R$387M. The stock trades on a trailing P/E of 0.4. Fundamentals as of Jul 11, 2026
Our scenario range runs from R$0.4073 (bear case) to R$1.76 (bull case); at R$1.60, the current price sits within that range. The share trades about 30% below its 52-week high and 10% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Cyclical peers we cover trades at 29% fair-value upside — at -25%, RSID3 screens richer than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 11, 2026. TTM = trailing twelve months.
About the company
Rossi Residencial S.A., together with its subsidiaries, engages in the construction, development, and sale of land subdivision in Brazil. The company markets real estate and residential properties, and commercial land. It also provides civil engineering services. The company was incorporated in 1980 and is headquartered in São Paulo, Brazil.
Revenue & earnings trend
FY2020 – FY2024 · reported fiscal years
Rossi Residencial S.A reported revenue of R$146M in FY2024 versus R$105M in FY2020, a compound +8.7%/yr. Reported net income was R$85.3M in FY2024, compounding +54.6%/yr from FY2020.
Is RSID3 fairly valued? → Check now
Similar stocks
10 more Residential Construction stocks, each showing price versus our Fair Value estimate (as of Jul 11, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| D.R. Horton, Inc D1HI34 | R$810.00 | R$845.83 | +4% |
| PulteGroup, Inc P1HM34 | R$637.18 | R$154.88 | -76% |
| Lennar Corporation LEN | $87.44 | $142.47 | +63% |
| NVR, Inc NVR | $6,305 | $6,172 | -2% |
| Toll Brothers, Inc TOL | $138.90 | $127.31 | -8% |
| Sekisui House, Ltd SKHSY | $19.87 | $35.50 | +79% |
| Taylor Morrison Home Corporation TMHC | $71.53 | $95.27 | +33% |
| Installed Building Products, Inc IBP | $202.74 | $121.62 | -40% |
| Sumitomo Forestry Co SMFRF | $7.98 | $11.72 | +47% |
| Persimmon Plc, PSMMF | $15.26 | $19.67 | +29% |
Explore undervalued stocks
More undervalued Consumer Cyclical stocks →
Frequently asked questions
Is Rossi Residencial S.A (RSID3) undervalued?
What is the fair value of RSID3?
What is the quality score of RSID3?
What is the revenue of Rossi Residencial S.A (RSID3)?
What is the net profit margin of RSID3?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Unlock the full Rossi Residencial S.A analysis — and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.